Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Binh Dinh Pharmaceutical And Medical Equipment JSC's quarterly buildings and improvements
increased
from Dec. 2025 (₫234,506 Mil) to Mar. 2026 (₫234,724 Mil) but then
declined
from Mar. 2026 (₫234,724 Mil) to Jun. 2026 (₫233,877 Mil).
Binh Dinh Pharmaceutical And Medical Equipment JSC's annual buildings and improvements
increased
from Dec. 2023 (₫220,743 Mil) to Dec. 2024 (₫232,539 Mil) and
increased
from Dec. 2024 (₫232,539 Mil) to Dec. 2025 (₫234,506 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC Buildings And Improvements Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
Binh Dinh Pharmaceutical And Medical Equipment JSC Buildings And Improvements Calculation
Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.
Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.
What does a Buildings And Improvements of ₫233,877 Mil mean?
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a Buildings And Improvements of ₫233,877 Mil as of Jun. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's Buildings And Improvements too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current Buildings And Improvements is ₫233,877 Mil. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's Buildings And Improvements compare to ZTS?
Binh Dinh Pharmaceutical And Medical Equipment JSC's Buildings And Improvements of ₫233,877 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Drug Manufacturers company?
A good Buildings And Improvements depends on the Drug Manufacturers industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. Binh Dinh Pharmaceutical And Medical Equipment JSC's current Buildings And Improvements is ₫233,877 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,591.21, compared to a current price of ₫47,900.00 — trading 8.9% below its estimated fair value. The current Buildings And Improvements is ₫233,877 Mil. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current Buildings And Improvements is ₫233,877 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued.
The current stock price of ₫47,900.00 is trading 8.9% below its estimated GF Value™ of ₫52,591.21.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
Buildings And Improvements: ₫233,877 Mil
GF Value™: ₫52,591.21 vs. price of ₫47,900.00 (8.9% below fair value)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
80GF Score
Get the complete analysis for STC:DBD
Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
